Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous oxytocin before laparoscopic incision to reduce pain
ISRCTN29008609Phase 2Completed
- Sponsor
- Instituto de Neurobiología
- Start
- Feb 2016
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of oxytocin and lidocaine in acute postoperative pain (3 arms), sponsored by Instituto de Neurobiología. Primary endpoints: Nociceptive hemodynamic response to surgical incision and Post-surgical pain level. Started Feb 2016; status: completed.
02
Drugs
oxytocinlidocaine
03
Conditions
acute postoperative pain
Beyond the preview
Go deeper on ISRCTN29008609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN29008609.